AN UNBIASED VIEW OF PHARMACEUTICAL RAW MATERIALS/CHEMICALS

Such carryover should not cause the carryover of degradants or microbial contamination that may adversely alter the established API impurity profile.Acceptance standards for residues and the choice of cleansing strategies and cleansing agents need to be outlined and justified.Pharmaron supports the manufacturing of high-excellent drug products for